In cases of emerging viral pathogens such as Monkeypox Virus, when there is no test that can be conducted to validate the efficacy of a disinfectant, the US Environmental Protection Agency utilizes their Emerging Viral Pathogens Policy to determine the expected efficacy of a disinfectant against an emerging virus. In t

Virox Technologies, the creator and manufacturer of some of the world’s safest, most effective, eco-friendly disinfectant chemistries is pleased to announce the expansion of their partnership with Contec, Inc. Virox and Contec have partnered together for well over a decade marketing, promoting, and selling Virox’s

Corynebacterium bovis (C. bovis), which causes scaly skin disease in rodents, poses a substantial threat to laboratory animal research. As these bacteria are associated with fomite transmission, cleaning and disinfection are essential to prevent C. bovis infection. Peroxigard™ Ready-to-Use liquid and Wipes offer a un

Peroxigard® (US) Ready-to-Use One-Step Disinfectant Cleaner & Deodorizer (EPA Reg. No. 74559-9) has received an EPA-approved label efficacy claim for use against Corynebacterium bovis (C. bovis). For use against C. bovis, a 2-minute contact time should be followed after application and users should follow the C. b

Peroxigard® (US) One-Step Disinfectant Cleaner & Deodorizer Wipes (EPA Reg. No. 74559-10) has received an EPA-approved label efficacy claim for use against Corynebacterium bovis (C. bovis). As such, Peroxigard has been validated through independent testing at an EPA-recognized laboratory to be effective against C.